A new phase 3 trial evaluated whether a quadrivalent modified mRNA influenza vaccine could match or exceed the efficacy of a licensed inactivated influenza vaccine in adults aged 18–64 years during the...
On Friday, the Advisory Committee on Immunization Practices voted 8-3 on major changes to the long-standing universal hepatitis B birth-dose policy, introducing shared decision-making for infants born to...
Recent studies examine metformin for long COVID prevention, resistance exercise for post-COVID recovery, mRNA vaccines in cancer care, and vascular risks in children.
A large systematic review and meta-analysis published in the Journal of the American Heart Association evaluated evidence from 155 studies worldwide, identifying strong associations between several viral...
For oncologists considering immunotherapy sequencing, a Nature report from MD Anderson Cancer Center in Houston, TX, suggests that receipt of a SARS-CoV-2 mRNA vaccine near the start of immune checkpoint...
Federal, professional, and state guidance on COVID-19 vaccination diverge significantly this fall. This guide synthesizes the latest recommendations to help clinicians counsel patients and ensure access.
...
In a nationwide Danish trial of more than 130,000 adults aged 60 years and older, a single dose of the bivalent RSV prefusion F protein vaccine reduced all-cause cardiorespiratory hospitalizations by nearly...
New studies highlight that while persistent SARS-CoV-2 infections can evolve rapidly within individuals, they rarely spread onward. Meanwhile, the 2024–2025 COVID-19 vaccine reduced mortality by 64% among...
In this roundup, experts outline diverging pediatric COVID vaccine recommendations, midlife peaks in long COVID risk, new findings on abnormal uterine bleeding and cycle-related symptoms in long COVID, and...
